SCHEMBL215511

SCHEMBL215511

CCc1[c]ccc(C)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11417292 0.83 ACHE (0.33)
SCHEMBL17818217 0.83 ACHE (0.33)
SCHEMBL1777552 0.82 TSHR (0.31)
SCHEMBL28781258 0.80 TAAR1 (0.32)
SCHEMBL9743951 0.79
SCHEMBL10461759 0.79
SCHEMBL2170603 0.79
SCHEMBL6936966 0.79
SCHEMBL5773093 0.79
SCHEMBL18322737 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 641 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109369835-A For the cyclopentadienyl rare-earth metal carbon monoxide-olefin polymeric of alpha-olefine polymerizing and its application 朱博源 2019-02-22 CN claimed
CN-109369837-A A kind of metallocene catalyst compositions and its application for alpha-olefine polymerizing 朱博源 2019-02-22 CN claimed
WO-2016061393-A1 FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE XENOPORT, INC. (US) 2016-04-21 WO claimed
EP-1613587-B1 ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2009-12-30 EP claimed
WO-2008029278-A2 CONJUGATES OF ANTITHROMBIN BINDING OLIGOSACCHARIDE DERIVATIVES AND THERAPEUTIC PROTEINS ENDOTIS PHARMA S.A. (FR) 2008-03-13 WO claimed
EP-1886696-A1 Conjugates of antithrombin binding oligosaccharide derivatives and therapeutic proteins Endotis Pharma (FR) 2008-02-13 EP claimed
WO-2007135529-A2 AZABENZIMIDAZOLYL COMPOUNDS AS MGLUR2 POTENTIATORS PFIZER PRODUCTS INC. (US) 2007-11-29 WO claimed
WO-2007135417-A1 BENZOTRIAZEPINONE DERIVATIVES JAMES BLACK FOUNDATION (GB) 2007-11-29 WO claimed
WO-2007135350-A1 BENZOTRIAZEPINONE DERIVATIVES JAMES BLACK FOUNDATION (GB) 2007-11-29 WO claimed
WO-2006129120-A9 BENZOTRIAZEPINONE DERIVATIVES JAMES BLACK FOUNDATION (GB) 2007-03-22 WO claimed
WO-2006129120-A2 BENZOTRIAZEPINONE DERIVATIVES JAMES BLACK FOUNDATION (GB) 2006-12-07 WO claimed
US-20060270588-A1 Organic compounds GIVAUDAN SA (CH) 2006-11-30 US claimed
EP-1199310-B1 PROCESS FOR THE PREPARATION OF CONDENSED PHOSPHORIC ESTERS DAIHACHI CHEM IND (JP) 2003-11-05 EP claimed
JP-57165357-A None JP disclosed
CN-110300804-B Method for synthesizing DNA conjugate by micelle catalysis 多特蒙德工业大学 2024-02-02 CN disclosed
CN-115151538-A Macrocyclic compounds, process for their preparation and pharmaceutical compositions containing them 法国施维雅药厂 2022-10-04 CN disclosed
US-4001300-A ANTIULCER, DECONGESTANT, LABOR INDUCER, WOUND HEALER THE UPJOHN COMPANY (US) 1977-01-04 US disclosed
US-3974146-A Cyanolpoxy intermediates for prostaglandins and process for preparing same THE UPJOHN COMPANY (US) 1976-08-10 US disclosed
US-3971747-A ORGANO-SILICON, EPOXIDE, ALUMINUM CONTAINING CATALYST DOW CORNING CORPORATION (US) 1976-07-27 US disclosed
US-3931279-A 5-Oxa prostaglandin F2.sub.α analogs THE UPJOHN COMPANY (US) 1976-01-06 US disclosed